Patent · US Active

Antibodies to NTB-A

US8193320B2 · kind B2 · utility

1Cited by

2References

17Claims

0Family size

Assignee

ARCA Biopharma, Inc. · US

Inventors

Arie Abo · Oakland, US
Wouter Korver · South San Francisco, US

Key dates

Filing date	Dec 7, 2010
Grant date	Jun 5, 2012
Priority date	—
Expiry date	Dec 7, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Anti-NTB-A antibodies and antigen-binding fragments thereof, as well as pharmaceutical compositions comprising such antibodies and antigen-binding fragments are described. Also described are methods of using such antibodies and antigen-binding regions to bind NTB-A and treat diseases, such as hematologic malignancies, which are characterized by expression of NTB-A.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.